Q3 Top Pharma Company Earnings Reports

The summer is fading fast, the leaves are changing from green to gold and red, and days have gotten shorter as we turn our clocks back from daylight savings time. So what season is upon us? Earnings season of course!

We've compiled the earnings reports from some of the top companies in Pharma with brief summaries, links to some of our articles and some quick highlights of some of the more important facts. Check out the list below or just click through all of our reports on these companies:

Read more on

Suggested Articles

With a brand new approval for Adakveo under its belt, Novartis Sunday flaunted an analysis showing the drug could cut patient hospitalizations by 40%.

BeiGene only just won its first Brukinsa nod in MCL. But it’s already pushing to join the CLL field, and Sunday it rolled out more data.

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.